---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-21-002587"
form_type: "8-K"
ticker: "UTMD"
cik: "0000706698"
company_name: "UTAH MEDICAL PRODUCTS INC"
filed_at: "2021-10-26T23:59:59+00:00"
generated_at: "2026-06-28T18:12:24.800357+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# UTMD Q3 2021 EPS $1.150, revenue up 20%; 9M non-GAAP EPS $3.021, up 46%

## Summary
- Q3 2021 net income $4.2M (33.5% of sales), up 43.4% YoY; diluted EPS $1.150.
- 9M 2021 US GAAP net income $10.7M, up 44.3%; non-GAAP net income $11.0M, up 45.1%.
- Cash and investments at Sep 30, 2021: $64.3M, up from $51.6M at Dec 31, 2020.
- Management expects FY2021 adjusted EBITDA >$26M ($28M for 2022).
- Dividend increased to $0.285/share; total 9M dividends $3.1M.

## SEC filing metadata
- accession: 0001096906-21-002587
- form_type: 8-K
- ticker: UTMD
- cik: 0000706698
- company_name: UTAH MEDICAL PRODUCTS INC
- filed_at: 2021-10-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01, 99.1
- EDGAR index: https://www.sec.gov/Archives/edgar/data/706698/000109690621002587/0001096906-21-002587-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/706698/000109690621002587/utmd-20211026.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-21-002587
- JSON: https://secwatch.observer/filing/0001096906-21-002587.json
- Plain text: https://secwatch.observer/filing/0001096906-21-002587.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.